Results 301 to 310 of about 156,800 (338)
Some of the next articles are maybe not open access.

Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.

Journal of Pharmacology and Experimental Therapeutics, 1997
G. Fischer   +7 more
semanticscholar   +1 more source

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

2017
Anti- N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe but treatable recently identified form of immune-mediated encephalitis associated with antibodies in serum and cerebrospinal fluid (CSF) against the GluN1 subunit of the NMDAR. Research has rapidly expanded the understanding of disease mechanisms and how the condition manifests in ...
openaire   +1 more source

N‐Methyl‐D‐Aspartate Receptors and Ethanol: Inhibition of Calcium Flux and Cyclic GMP Production

Journal of Neurochemistry, 1989
P. Hoffman   +3 more
semanticscholar   +1 more source

N-Methyl-D-Aspartate (NMDA) Receptor Antagonists

Abstract N-methyl-D-aspartate (NMDA) receptor antagonists are a group of drugs used widely in medicine as anesthetics. These agents work by inhibiting the NMDA receptor, a glutamate and ion channel protein receptor, thereby providing analgesia, sedation, and amnesia. There are several NMDA receptor antagonist agents available with varied
Ethan R. Leonard, Maxim S. Eckmann
openaire   +1 more source

Home - About - Disclaimer - Privacy